Warberg Asset Management »

Esperion Therapeutics shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 374k 3.16
2023-09-30 $13k 13k 0.98

More positions owned by Warberg Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Granite Constr Note 3.750% 5/1 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Astronics Corp Note 5.500% 3/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Nextnav Common Stock (NN)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Cornerstone Strategic Value (CLM)
Guardant Health Debt 1.250% 2/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)
Txnm Energy Note 5.750% 6/0 (Principal)
Liberty Media Corp Del Note 3.750% 3/1 (Principal)
Core Scientific *w Exp 01/23/202 (CORZW)
Ormat Technologies Note 2.500% 7/1 (Principal)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)

View all positions for Warberg Asset Management

Top funds holding Esperion Therapeutics

Glazer Capital
BlackRock
Vanguard Capital Management
Trium Capital
Goldman Sachs Group
Two Sigma Investments
State Street Corporation
Geode Capital Management
CNH Partners
Oddo Bhf Asset Management Sas
Balyasny Asset Management
FMR
Beryl Capital Management
PenderFund Capital Management
UBS Group

View all funds holding Esperion Therapeutics